Cite

HARVARD Citation

    Trethewey, C. et al. (2022). Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type. HemaSphere. 6 (3), pp. e690-. [Online]. 
  
Back to record